does pfizer have a glp-1 drug China has approved Pfizer's treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in market Pfizer, Novo Nordisk bidding war
Description
Real-world Evidence: There is mounting evidence that GLP-1 agonists administered for diabetes or obesity correspond to reduced addiction risk
There is a pressing need to expand clinical trial evidence to solidify their therapeutic role in non-diabetic populations for primary prevention and for specific conditions, such as vascular dementia
Rising prevalence of diabetes worldwide, coupled with growing patient awareness and expanding healthcare access, is fueling market expansion
Check if your employer offers GLP-1 coverage Corporate benefits packages increasingly include GLP-1 medication coverage
Methods Cell
Your doctor can provide guidance on the best course of action based on your specific health situation.
